In which of the following conditions will you perform the Kasai procedure? A. Extrahepatic biliary atresia [54%] B. Type 1 choledochal cyst [17%] C. Caroli disease [25%] D. Cholangiocarcinoma [4%]
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Answer: A. Extrahepatic biliary atresia
The correct answer is A, with 54% of examinees selecting it correctly.
The Kasai Procedure (Hepatoportoenterostomy)
The Kasai procedure (hepatic portoenterostomy) was first described by Morio Kasai in 1959 and is the standard surgical treatment for extrahepatic biliary atresia (EHBA). It is not performed for the other conditions listed.
What it involves:
- Exploratory laparotomy
- Excision of the occluded extrahepatic biliary system (the fibrosed, obliterated bile ducts)
- A Roux-en-Y jejunal anastomosis to the transected fibrotic cord at the porta hepatis, where microscopic residual bile channels have been confirmed by frozen section
Kasai's original observation was that microscopic bile channels persist in the fibrous tissue at the porta hepatis even when the macroscopic ducts are obliterated - the operation exploits these remnant channels to restore bile flow.
Why not the other options?
| Condition | Correct Management |
|---|---|
| Type 1 Choledochal cyst | Cyst excision with Roux-en-Y hepaticojejunostomy (not Kasai) |
| Caroli disease | Endoscopic/percutaneous drainage, ursodeoxycholic acid, partial hepatectomy (for localized), or liver transplant |
| Cholangiocarcinoma | Surgical resection (Whipple, hepatic resection) +/- biliary bypass for palliation; liver transplant in select hilar cases |
Key detail for EHBA classification: Type III EHBA (>90% of cases) involves the left and right hepatic ducts at the porta hepatis - this is the classic indication for Kasai. Types I and II may be amenable to direct biliary-intestinal anastomosis.
Outcomes after Kasai
- Best outcomes when performed within the first 45 days of life (65.5% native liver survival at 2 years)
- Overall: ~40-60% 5-year survival after portoenterostomy
- One-third do well long-term with no transplant needed
- One-third require early liver transplantation
- One-third have slow progressive dysfunction and eventually need transplant
- The Kasai procedure is always first-line, as it preserves the option of liver transplant later and bridges patients through growth
(Sources: Yamada's Textbook of Gastroenterology 7e; Sabiston Textbook of Surgery)
When should primary liver transplant be considered instead of Kasai procedure?
why not cholangiocarcinoma as in klastin tumor kasai is done
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Here are comprehensive answers to both your questions:
Q1: When is Primary Liver Transplant Preferred Over Kasai?
The standard teaching is that Kasai is always attempted first in biliary atresia, with liver transplant reserved for specific situations. From the textbooks:
Primary Liver Transplant is Indicated Instead of Kasai When:
| Situation | Rationale |
|---|---|
| Late presentation with advanced cirrhosis | If the infant presents late (beyond ~90-100 days) with established cirrhosis and signs of liver failure, Kasai is unlikely to achieve bile drainage and transplant is the primary option |
| Failed Kasai procedure | No bile drainage or progressive liver failure after Kasai - the most common reason for eventual transplant |
| Established liver failure at diagnosis | Signs: ascites, severe coagulopathy, hepatomegaly, failure to thrive from cirrhosis |
Key Numbers to Remember:
- Kasai done within 45 days - best outcomes (65.5% native liver survival at 2 years)
- Kasai done after 90-100 days - progressively worse outcomes; transplant more likely primary option
- Despite a "recent high-profile paper" (referring to a 2020s trial) suggesting primary liver transplant for all BA, current standard remains Kasai-first, with transplant reserved for late presenters and Kasai failures (Fischer's Mastery of Surgery)
- 80% of those who undergo a successful Kasai can live up to 10 years before needing transplant
- Post-transplant outcomes are good: 10-year graft survival 73%, patient survival 86% (Sabiston)
Q2: Why NOT Cholangiocarcinoma / Klatskin Tumor?
This is a very valid question because people sometimes confuse the terms. Here is the key distinction:
The Kasai Procedure vs. Surgery for Klatskin Tumors
The Kasai procedure is a specific operation for neonatal biliary atresia. It involves:
- Excision of fibrous obliterated ducts at the porta hepatis
- Roux-en-Y portoenterostomy to drain residual microscopic bile channels
Klatskin tumor (perihilar cholangiocarcinoma) is a malignancy at the hepatic duct bifurcation. Its surgery is completely different:
| Feature | Biliary Atresia (Kasai) | Klatskin Tumor |
|---|---|---|
| Patient age | Neonates (first weeks of life) | Adults (50-70 years) |
| Pathology | Fibro-inflammatory obliteration of ducts | Adenocarcinoma |
| Goal of surgery | Restore bile flow via portoenterostomy | Achieve R0 (margin-negative) resection |
| Operation | Kasai portoenterostomy (Roux-en-Y) | Hepatic resection + bile duct excision + caudate lobe resection (Bismuth-Corlette classification guides extent) |
| Liver transplant role | For failed Kasai / late presentation | For unresectable hilar CCA (select cases, Mayo protocol) |
Why the Confusion?
Both conditions involve the porta hepatis and bile duct obstruction, but:
- In Klatskin tumors, the ducts are patent but obstructed by tumor - you need to resect the cancer
- In biliary atresia, the ducts are obliterated/absent - you need to bypass them with bowel
Performing a "Kasai-type" portoenterostomy on a Klatskin tumor would leave cancer behind - it would be a non-curative palliative bypass, not the Kasai procedure. For unresectable Klatskin tumors, biliary bypass is done for palliation, but this is distinct from the Kasai operation and is never the first-line approach.
In summary: the Kasai procedure is a pediatric operation for a congenital condition. When MCQs mention cholangiocarcinoma with "Kasai," it is a distractor testing whether you know the procedure's true indication.
(Sources: Sabiston Textbook of Surgery; Mulholland & Greenfield's Surgery; Fischer's Mastery of Surgery 8e)
This is a shared conversation. Sign in to Orris to start your own chat.